Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Purified Inactivated Japanese Encephalitis Vaccine (Vero cell) 0–7 vs 0–28 day schedule in infants
CTR20180060Phase 3Completed
- Sponsor
- Institute of Medical Biology
- Start
- May 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Vero cell-derived inactivated Japanese Encephalitis vaccine in Japanese encephalitis (JE), sponsored by Institute of Medical Biology. Started May 2018; status: completed.
02
Drugs
Vero cell-derived inactivated Japanese Encephalitis vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on CTR20180060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180060.